Cian Healthcare Limited IPO is all about to make its debut on May 02, 2019 with issue size of INR 37.92cr
Cian Healthcare Limited, a global manufacturer founded in 2003, has received certification from the WHO-GMP, ISO 9001:2015, and the Food and Drug Control Administration to operate in the fields of food supplements, sexual wellness, cosmetics, nutraceuticals, ayurvedic medicine, and pharmaceutical products. The company’s manufacturing procedure complies with the World Health Organization’s set standards and guidelines.
The business is involved in the development, production, and marketing of pharmaceutical goods under the auspices of 12 therapeutic divisions and 10 sales divisions. The business is run by the corporation under the name, and it also engages in government contracting, exporting, and third-party production.The company’s product line consists of tablets, gels, lotions, creams, ointments, liquid oral preparations, capsules, and tablets. In addition, the business has a unique licence to produce veterinary products like Venky’s and SAVAvet. The business produces pharmaceuticals for both the domestic and international markets.
INDUSTRY OVERVIEW
Even though it has slightly slowed down, the global growth rate is still high and is expected to reach 3.1% in 2018. But, it is anticipated to slow rapidly during the following two years as trade and investment level off, financing conditions tighten, and global slack disappears. The normalisation of monetary policy and diminished impacts of U.S. fiscal stimulus are expected to cause advanced nations’ growth to slow down near potential rates. Contrarily, the rise of commodity importers in emerging market and developing economies (EMDEs) will continue to be strong, and the recovery of commodity exporters is anticipated to reach maturity over the next two years.
Long-term consensus predictions for global growth have stabilised, but historical experience has shown that these predictions are typically overly optimistic. These projections are still below levels projected 10 years ago, even if they are still higher than estimates of prospective growth. The risks associated with the prognosis are also tilted to the downside and include erratic financial market movements, rising trade protectionism, and escalating geopolitical tensions.
Cian Healthcare IPO Details
| IPO Date | May 2, 2019 to May 15, 2019 |
| Listing Date | Thursday, May 23, 2019 |
| Face Value | ₹10 per share |
| Price | ₹59 to ₹65 per share |
| Lot Size | 2000 Shares |
| Issue Size | 6,216,000 shares of ₹10 (aggregating up to ₹37.92 Cr) |
| Market Maker portion | 316,000 shares |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Company Promoters | Suraj Zanwar & Kavita Zanwar are the promoters of the company. |
Cian Healthcare IPO Tentative Dates
Cian Healthcare IPO opens on May 2, 2019, and closes on May 15, 2019. The Cian Healthcare IPO bid date is from May 2, 2019 10.00 A.M. to May 15, 2019 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 5 PM on the issue closing day.
| Event | Tentative Date |
|---|---|
| Opening Date | May 2, 2019 |
| Closing Date | May 15, 2019 |
| Basis of Allotment | May 20, 2019 |
| Initiation of Refunds | May 21, 2019 |
| Credit of Shares to Demat | May 22, 2019 |
| Listing Date | May 23, 2019 |
Company Financials
| Particulars | For the year/period ended (in Rs. Lakhs) | |||
|---|---|---|---|---|
| 31-Dec-18 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | |
| Total Assets | 8,590.11 | 7,762.47 | 6,127.82 | 5,681.81 |
| Total Revenue | 4,407.21 | 5,941.70 | 5,178.32 | 4,668.21 |
| Profit After Tax | 525.03 | 375.65 | 223.64 | 137.20 |
Objects of the Issue
The Company intends to allocate the Net Proceeds raised from the issue to achieve the following goals:
- Improve the existing plant located in Roorkee, Uttarakhand, India, namely Unit 1.
- Provide Margin Money to establish a new manufacturing facility, namely Unit 2, situated in Roorkee, Uttarakhand, India.
- Boost the Company’s brand recognition through advertising and other brand-building initiatives.
- Meet long-term working capital needs.
- Pursue acquisitions and other strategic opportunities.
- Fund general corporate purposes.
Cian Healthcare IPO Prospectus
Company Contact Information
Cian Healthcare Limited
Milkat No. 3339, Block No.1,
From South Side, C.S.No.227 /2 + 3A, Harpale Park,
Opp Berger Paint, Phursungi, Pune- 412308
Phone: 020-41471234 /265
Email: cs@cian.co
Website: https://www.cian.co/
Cian Healthcare IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: investor@bigshareonline.com
Website: https://www.bigshareonline.com/
Cian Healthcare IPO Lead Manager(s)
- Fedex Securities Limited (Past IPO Performance)
